Compositions useful in the prevention and/or treatment of osteoarticular inflammation and pain and cartilage damage

US10583162B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10583162-B2
Application numberUS-201716313202-A
CountryUS
Kind codeB2
Filing dateJun 28, 2017
Priority dateJun 29, 2016
Publication dateMar 10, 2020
Grant dateMar 10, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to compositions comprising: a) a Vitis vinifera extract in free form or in the form of a complex with phospholipids, or a Punica granatum extract; and b) a lipophilic extract of Zingiber officinale; and c) a lipophilic extract obtained from plants containing polyunsaturated fatty acid isobutylamides selected from the group consisting of Echinacea spp. extract or Zanthoxylum spp. extract or Acmella oleracea (or Spilanthes oleracea) extract; and d) an unsaponifiable fraction of olive oil and/or corn oil; or e) N-acetyl glucosamine; or f) diacerein; and their use in the prevention and/or treatment of osteoarticular inflammation and pain, and cartilage damage.

First claim

Opening claim text (preview).

The invention claimed is: 1. A composition comprising: a) an extract of Vitis vinifera in free form or in the form of a complex with phospholipids, or an extract of Punica granatum in amounts ranging from 50 to 1000 mg; b) a lipophilic extract of Zingiber officinale in amounts ranging from 10 to 80 mg; c) a lipophilic extract of Zanthoxylum spp. in amounts ranging from 1 to 50 mg or, alternatively, a lipophilic extract of Echinacea spp. or of Acmella oleracea in amounts ranging from 5 to 50 mg; and d) an unsaponifiable fraction of olive oil and/or corn oil in amounts ranging from 50 to 500 mg; or e) N-acetylglucosamine in amounts ranging from 50 to 500 mg; or f) diacerein in amounts ranging from 20 to 200 mg. 2. The composition according to claim 1 , comprising: a) an extract of Vitis vinifera seeds in free form or in the form of a complex with phospholipids, or an extract of Punica granatum in amounts ranging from 50 to 1000 mg; and b) a lipophilic extract of Zingiber officinale in amounts ranging from 10 to 80 mg; and c) a lipophilic extract of Zanthoxylum spp. in amounts ranging from 1 to 50 mg or, alternatively, a lipophilic extract of Echinacea spp. or of Acmella oleracea in amounts ranging from 5 to 50 mg; and d) an unsaponifiable fraction of olive oil in amounts ranging from 50 to 500 mg. 3. The composition according to claim 1 , for oral administration comprising per dosage unit: a) an extract of Vitis vinifera in free form or in the form of a complex with phospholipids, or an extract of Punica granatum , in amounts ranging from 50 to 1000 mg; b) a lipophilic extract of Zingiber officinale in amounts ranging from 10 to 80 mg; c) a lipophilic extract of Zanthoxylum spp. in amounts ranging from 1 to 50 mg or, alternatively, a lipophilic extract of Echinacea spp. or of Acmella oleracea in amounts ranging from 5 to 50 mg; d) an unsaponifiable fraction of olive oil in amounts ranging from 50 to 500 mg. 4. The composition according to claim 3 , comprising: a) an extract of Vitis vinifera in free form or in the form of a complex with phospholipids, or an extract of Punica granatum , in the amount of 200 mg; b) a lipophilic extract of Zingiber officinale in the amount of 50 mg; c) a lipophilic extract of Zanthoxylum spp. in the amount of 20 mg or, alternatively, a lipophilic extract of Echinacea spp. or of Acmella oleracea in the amount of 10 mg; d) an unsaponifiable fraction of olive oil in the amount of 150 mg. 5. The composition according to claim 1 comprising: a) an extract of Vitis vinifera in free form or in the form of a complex with phospholipids, or an extract of Punica granatum in amounts ranging from 50 to 1000 mg; b) a lipophilic extract of Zingiber officinale in amounts ranging from 10 to 80 mg; and c) a lipophilic extract obtained from plants containing polyunsaturated fatty acid isobutylamides selected from the group consisting of Echinacea spp. extract, Zanthoxylum spp. extract and Acmella oleracea extract in amounts ranging from 5 to 50 mg; d) N-acetylglucosamine in amounts ranging from 50 to 500 mg; or e) diacerein in amounts ranging from 20 to 200 mg. 6. The composition according to claim 5 comprising a) an extract of Vitis Vinifera in a free form or in the form of a complex with phospholipids, or an extract of Punica granatum in the amount of 200 mg; b) a lipophilic extract of Zingiber officinale in the amount of 50 mg; c) a lipophilic extract of Zanthoxylum spp. in the amount of 20 mg or, alternatively, a lipophilic extract of Echinacea spp. or of Acmella oleracea in the amount of 10 mg; d) N-acetylglucosamine in the amount of 150 mg; or e) diacerein in the amount of 50 mg. 7. The composition according to claim 5 , comprising: a) an extract of Vitis vinifera complexed with phospholipids in the amount of 200 mg; b) a lipophilic extract of Zingiber officinale , containing 30% w/w of gingerols and shogaols, in the amount of 50 mg; c) a lipophilic extract of Zanthoxylum spp. in the amount of 10 mg; d) an unsaponifiable fraction of olive oil in the amount of 100 mg; or e) N-acetylglucosamine in the amount of 150 mg; or f) diacerein in the amount of 50 mg. 8. The composition according to claim 1 , for topical administration comprising: a) an extract of Vitis vinifera complexed with phospholipids in amounts ranging from 0.1 to 2.5% w/w; b) a lipophilic extract of Zingiber officinale in amounts ranging from 0.1 to 1% w/w; c) a lipophilic extract of Zanthoxylum spp. in amounts ranging from 0.1 to 1% w/w; d) an unsaponifiable fraction of olive oil in amounts ranging from 0.1 to 1% w/w. 9. The composition according to claim 7 , comprising: a) the extract of Vitis vinifera complexed with phospholipids in the amount of 1% w/w; b) the lipophilic extract of Zingiber officinale in the amount of 0.5% w/w; c) the lipophilic extract of Zanthoxylum spp. in the amount of 0.5% w/w; d) the unsaponifiable fraction of olive oil in the amount of 0.5% w/w. 10. The composition according to claim 1 , wherein Punica granatum extract is characterised by a 40% w/w content of punicalagins. 11. The composition according to claim 1 , wherein the lipophilic extract of Zingiber officinale is characterised by a 30% w/w content of gingerols and shogaols. 12. The composition according to claim 1 , wherein the unsaponifiable fraction of olive oil is characterized by a content in terpenes and polyalcohols ranging from 40 to 90% w/w. 13. The composition according to claim 1 for use in the prevention and/or treatment of inflammation and pain. 14. The composition for use according to claim 13 , wherein said inflammation and said pain comprise osteoarticular inflammation, pain, and cartilage damage. 15. The composition for use according to claim 13 , wherein said pain is systematic pain or peripheral pain in small and large joints, said joints comprising knee and femoral sockets. 16. The composition for use according to claim 15 , wherein said peripheral pain is due to diabetic neuropathy, neuropathy induced by chemotherapy, muscle pains and inflammatory states comprising cutaneous inflammations. 17. A composition comprising: a) an extract of Vitis vinifera in free form or in the form of a complex with phospholipids, or an extract of Punica granatum in amounts ranging from 200 to 250 mg; b) a lipophilic extract of Zingiber officinale in the amount of 50 mg; c) a lipophilic extract obtained from plants containing polyunsaturated fatty acid isobutylamides selected from the group consisting of Echinacea spp. extract, Zanthoxylum spp. extract and Acmella oleracea extract in amounts ranging from 15 to 20 mg; d) an unsaponifiable fraction of olive oil and/or corn oil in the amount of 150 mg; or e) N-acetylglucosamine in the amount of 150 mg; or f) diacerein in the amount of 50 mg.

Assignees

Inventors

Classifications

  • Oleaceae (Olive family), e.g. jasmine, lilac or ash tree · CPC title

  • Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane · CPC title

  • having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid · CPC title

  • Compounds of unknown constitution, e.g. material from plants or animals (oils, fats, waxes, shellac A61K9/4858) · CPC title

  • A61K31/16Primary

    Amides, e.g. hydroxamic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10583162B2 cover?
The present invention relates to compositions comprising: a) a Vitis vinifera extract in free form or in the form of a complex with phospholipids, or a Punica granatum extract; and b) a lipophilic extract of Zingiber officinale; and c) a lipophilic extract obtained from plants containing polyunsaturated fatty acid isobutylamides selected from the group consisting of Echinacea spp. extract or Za…
Who is the assignee on this patent?
Indena Spa
What technology area does this patent fall under?
Primary CPC classification A61K31/16. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).